Kaitlin Ashley Zompanti is a Burlington, Massachusetts based nurse practitioner. Active license number of Kaitlin Ashley Zompanti is RN2289441 for Family in Massachusetts. Her current practice location is 101 Middlesex Tpke Ste 330, Burlington. Patients can reach her at 781-647-1500. Kaitlin Ashley Zompanti is NP and her NPI number (Unique professional ID assigned by NPPES) is 1639713902. Kaitlin Ashley Zompanti has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Kaitlin Ashley Zompanti speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1639713902
NPI Enumeration Date:
30 Oct, 2019
NPI Last Update On:
31 Jul, 2023
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Kaitlin Ashley Zompanti are as mentioned below.
License Number
Specialization
State
Status
RN2289441
Family
Massachusetts
Primary
RN2289441
Registered Nurse
Massachusetts
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Patients can reach Kaitlin Ashley Zompanti at 101 Middlesex Tpke Ste 330, Burlington, Massachusetts or can call to book an appointment on 781-647-1500.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 January, 2025.